rosiglitazone has been researched along with Aortic Aneurysm in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cockerill, GW; Howe, F; Pirianov, G; Torsney, E | 1 |
1 other study(ies) available for rosiglitazone and Aortic Aneurysm
| Article | Year |
|---|---|
Rosiglitazone negatively regulates c-Jun N-terminal kinase and toll-like receptor 4 proinflammatory signalling during initiation of experimental aortic aneurysms.
Topics: Angiotensin II; Animals; Aortic Aneurysm; Aortic Rupture; Down-Regulation; JNK Mitogen-Activated Protein Kinases; Mice; Phosphorylation; Rosiglitazone; Signal Transduction; Thiazolidinediones; Toll-Like Receptor 4 | 2012 |